Brief: POINT Biopharma Posts Qtrly Loss Per Share $0.18
May 13 (Reuters) - POINT Biopharma Global Inc PNT.O :
* POINT BIOPHARMA REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATE
* POINT BIOPHARMA GLOBAL INC QTRLY LOSS PER SHARE $0.18
* POINT BIOPHARMA GLOBAL INC - EXISITING CASH AND CASH
EQUIVALENTS, ANTICIPATED TO FUND OPERATIONS INTO Q1 OF 2024
Source text for Eikon: ID:nGNX5WFfVS
Further company coverage: PNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower